HON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Honeywell is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants a clear entry. The stock has some supportive long-term themes, especially the aerospace spin-off and Congress buying, but the latest quarter showed weaker fundamentals, analysts have been trimming price targets, and the technical setup is still mixed. My direct view: wait for a better entry rather than buy aggressively at the current pre-market price.
HON is trading pre-market at 214.00, slightly down -0.15%. The trend is still weak to neutral: MACD histogram is -1.625 and below zero, RSI_6 is 37.467, and moving averages are converging. Price is sitting just above key support near 209.914 (S1) and below pivot resistance at 220.847. That means the stock is not in a clean uptrend yet, but it is also not deeply oversold. The near-term pattern suggests only modest upside potential unless it reclaims the 220-231 zone.
In Q4 2025, Honeywell’s results were weaker year over year. Revenue fell to 9.758 billion, down 3.27% YoY, while net income dropped 77.04% to 295 million and EPS fell 76.53% to 0.46. Gross margin also slipped to 35.56%, down 2.25% YoY. The latest quarter season was weak overall, showing pressure on profitability more than top-line growth.
Recent analyst trend is mixed but leaning cautious. Several firms reduced price targets after Q1 results: Jefferies to $240 with Hold, Citi to $257 with Buy, TD Cowen to $230 with Buy, Barclays to $243 with Overweight, and Morgan Stanley to $245 with Equal Weight. Longer-term, some analysts remain constructive on the aerospace spin and portfolio transformation, but the wall Street pros and cons view is split: pros see spin-off catalysts, strong aerospace fundamentals, and valuation upside; cons focus on weaker near-term sales, lower earnings quality, and execution risk around the aerospace and remainco separation.
